ICL Group (NYSE: ICL) executive lists 945,558 options and share stake
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
ICL Group Ltd. executive Nadav Turner reports his initial holdings in company securities. He holds stock options covering 945,558 Ordinary Shares with an exercise price of $5.84 per share and an expiration on January 4, 2031. These options vest in three equal annual installments starting from the January 4, 2026 grant date and are held by a trustee in his name. He also holds 27,744 Ordinary Shares, which are likewise held by a trustee in his name.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Turner Nadav
Role
Pres, ICL Phosphate Sol
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Stock Options (Right to Buy) — 945,558 shares (Direct);
Ordinary Shares — 27,744 shares (Direct)
Footnotes (1)
- The Ordinary Shares are held by a Trustee in the name of the Reporting Person. The stock options vast in three equal annual installments from the January 4, 2026 grant date. Represents an exercise price of NIS 18.4, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.149 as of March 27, 2026. The options are held by a Trustee in the name of the insider.
Key Figures
Stock options underlying shares: 945,558 shares
Option exercise price: $5.84 per share
Option expiration date: January 4, 2031
+2 more
5 metrics
Stock options underlying shares
945,558 shares
Underlying Ordinary Shares for options held
Option exercise price
$5.84 per share
Exercise price for stock options
Option expiration date
January 4, 2031
Expiration of stock options
Ordinary Shares held
27,744 shares
Direct Ordinary Share holdings via trustee
Foreign exchange rate used
$1.00 = NIS 3.149
Rate used to convert NIS 18.4 option price
Key Terms
Stock Options (Right to Buy), Ordinary Shares, exercise price, vest in three equal annual installments, +1 more
5 terms
Stock Options (Right to Buy) financial
"security_title: "Stock Options (Right to Buy)""
exercise price financial
"Represents an exercise price of NIS 18.4, converted to U.S. dollars"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest in three equal annual installments financial
"The stock options vast in three equal annual installments from the January 4, 2026 grant date."
Trustee financial
"The Ordinary Shares are held by a Trustee in the name of the Reporting Person."
A trustee is a person or institution legally appointed to hold and manage assets or enforce an agreement on behalf of other people (beneficiaries). Think of a trustee as a neutral referee or custodian who must act in the beneficiaries’ best interests, follow the trust or contract rules, and handle distributions, recordkeeping and enforcement. Investors care because a trustworthy trustee protects their rights, ensures promised payments or remedies are delivered, and can influence recoveries if things go wrong.
FAQ
What does the ICL (ICL) Form 3 filing show for Nadav Turner?
The filing shows Nadav Turner’s initial holdings in ICL Group, including 945,558 stock options and 27,744 Ordinary Shares. These positions establish his baseline ownership as an officer, rather than reporting any new purchase or sale activity.
How many ICL (ICL) stock options does Nadav Turner hold?
Nadav Turner holds stock options over 945,558 ICL Ordinary Shares. These options carry an exercise price of $5.84 per share and vest in three equal annual installments beginning January 4, 2026, providing long-term equity-based compensation exposure.
What are the key terms of Nadav Turner’s ICL (ICL) stock options?
His stock options relate to 945,558 underlying Ordinary Shares at a $5.84 exercise price, expiring January 4, 2031. They vest in three equal annual installments from the January 4, 2026 grant date, aligning his incentives with longer-term company performance.
How was the $5.84 exercise price for ICL (ICL) options determined?
The exercise price reflects NIS 18.4 converted to U.S. dollars. The conversion used the Bank of Israel representative exchange rate of $1.00 to NIS 3.149 as of March 27, 2026, resulting in the disclosed $5.84 per-share price.